AbbVie Gross Margin vs Total Liabilities Analysis

ABBV Stock  USD 181.09  0.74  0.41%   
Trend analysis of AbbVie Inc balance sheet accounts such as Total Assets of 81.2 B, Other Current Liabilities of 32.2 B or Total Current Liabilities of 39.7 B provides information on AbbVie's total assets, liabilities, and equity, which is the actual value of AbbVie Inc to its prevalent stockholders. By breaking down trends over time using AbbVie balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About AbbVie Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of AbbVie Inc at a specified time, usually calculated after every quarter, six months, or one year. AbbVie Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of AbbVie and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which AbbVie currently owns. An asset can also be divided into two categories, current and non-current.

AbbVie Balance Sheet Chart

AbbVie Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how AbbVie Inc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, AbbVie's Deferred Long Term Liabilities is fairly stable compared to the past year.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of AbbVie assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AbbVie Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on AbbVie balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of AbbVie Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from AbbVie's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AbbVie Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Selling General Administrative is likely to drop to about 8 B in 2024. Tax Provision is likely to drop to about 811.5 M in 2024
 2021 2022 2023 2024 (projected)
Gross Profit38.8B40.6B45.5B25.2B
Total Revenue56.2B58.1B54.3B33.8B

AbbVie fundamental ratios Correlations

0.60.810.780.730.710.710.530.8-0.290.670.81-0.310.740.66-0.370.440.690.650.740.50.890.070.660.70.36
0.60.760.850.350.90.970.960.810.310.980.840.290.930.99-0.40.970.950.660.360.990.750.660.970.950.94
0.810.760.970.310.940.80.670.970.190.740.960.170.830.78-0.40.70.830.580.360.740.950.510.710.80.66
0.780.850.970.30.970.880.790.970.220.840.960.20.870.86-0.440.80.870.620.340.840.930.550.810.870.76
0.730.350.310.30.260.480.290.26-0.520.460.42-0.550.460.4-0.260.140.40.610.980.190.47-0.240.480.470.07
0.710.90.940.970.260.870.840.960.290.870.930.270.860.9-0.40.870.880.660.280.890.880.620.850.860.84
0.710.970.80.880.480.870.920.810.150.980.890.130.960.98-0.440.890.960.680.520.930.810.530.960.990.84
0.530.960.670.790.290.840.920.740.190.970.770.170.840.96-0.280.950.870.570.310.950.640.520.980.890.93
0.80.810.970.970.260.960.810.740.220.790.930.20.850.83-0.430.760.860.580.30.80.940.540.760.810.73
-0.290.310.190.22-0.520.290.150.190.220.130.171.00.170.19-0.280.460.22-0.05-0.510.420.10.910.10.160.53
0.670.980.740.840.460.870.980.970.790.130.840.110.920.99-0.360.930.940.690.470.950.750.51.00.960.88
0.810.840.960.960.420.930.890.770.930.170.840.150.880.85-0.460.770.880.590.480.810.920.510.820.880.74
-0.310.290.170.2-0.550.270.130.170.21.00.110.150.150.17-0.220.450.2-0.07-0.540.40.080.90.080.130.51
0.740.930.830.870.460.860.960.840.850.170.920.880.150.95-0.390.850.980.660.480.890.870.560.90.970.78
0.660.990.780.860.40.90.980.960.830.190.990.850.170.95-0.380.940.970.680.420.970.780.570.980.970.89
-0.37-0.4-0.4-0.44-0.26-0.4-0.44-0.28-0.43-0.28-0.36-0.46-0.22-0.39-0.38-0.35-0.42-0.29-0.29-0.37-0.41-0.36-0.35-0.43-0.33
0.440.970.70.80.140.870.890.950.760.460.930.770.450.850.94-0.350.890.550.160.990.650.750.920.870.99
0.690.950.830.870.40.880.960.870.860.220.940.880.20.980.97-0.420.890.640.440.930.820.590.910.980.83
0.650.660.580.620.610.660.680.570.58-0.050.690.59-0.070.660.68-0.290.550.640.570.590.650.290.680.690.46
0.740.360.360.340.980.280.520.310.3-0.510.470.48-0.540.480.42-0.290.160.440.570.210.49-0.220.490.520.08
0.50.990.740.840.190.890.930.950.80.420.950.810.40.890.97-0.370.990.930.590.210.70.730.930.920.97
0.890.750.950.930.470.880.810.640.940.10.750.920.080.870.78-0.410.650.820.650.490.70.450.720.810.59
0.070.660.510.55-0.240.620.530.520.540.910.50.510.90.560.57-0.360.750.590.29-0.220.730.450.470.540.77
0.660.970.710.810.480.850.960.980.760.11.00.820.080.90.98-0.350.920.910.680.490.930.720.470.940.88
0.70.950.80.870.470.860.990.890.810.160.960.880.130.970.97-0.430.870.980.690.520.920.810.540.940.82
0.360.940.660.760.070.840.840.930.730.530.880.740.510.780.89-0.330.990.830.460.080.970.590.770.880.82
Click cells to compare fundamentals

AbbVie Account Relationship Matchups

AbbVie fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding1.5B1.7B1.8B1.8B1.8B1.8B
Total Assets89.1B150.6B146.5B138.8B134.7B81.2B
Other Current Liab10.4B17.9B19.8B22.5B30.7B32.2B
Total Current Liabilities15.6B28.7B35.2B29.5B37.8B39.7B
Total Stockholder Equity(8.2B)13.1B15.4B17.3B10.4B7.1B
Other Liab18.5B30.4B31.0B31.7B36.5B38.3B
Property Plant And Equipment Net3.0B5.2B5.1B4.9B5.0B3.6B
Net Debt26.8B77.6B66.9B54.1B46.6B32.2B
Accounts Payable1.5B2.3B2.9B2.9B3.7B3.9B
Cash39.9B8.4B9.7B9.2B12.8B10.5B
Non Current Assets Total39.6B126.4B118.6B110.3B101.7B57.7B
Other Assets1.9B5.1B4.1B4.8B5.6B5.8B
Cash And Short Term Investments39.9B8.5B9.8B9.2B12.8B11.0B
Net Receivables5.4B8.8B10.0B11.3B11.2B6.8B
Good Will15.6B33.1B32.4B32.2B32.3B18.6B
Short Term Investments0.030M84M28M2M1.9M
Liabilities And Stockholders Equity89.1B150.6B146.5B138.8B134.7B81.2B
Non Current Liabilities Total81.7B108.8B95.9B92.0B86.5B55.5B
Inventory1.8B3.3B3.1B3.6B4.1B2.2B
Other Stockholder Equity(9.3B)15.1B15.2B14.7B13.6B7.1B
Total Liab97.3B137.5B131.1B121.5B124.3B74.1B
Property Plant And Equipment Gross3.0B5.2B10.7B11.0B11.6B12.2B
Total Current Assets49.5B24.2B27.9B28.5B33.0B23.5B
Accumulated Other Comprehensive Income(3.6B)(3.1B)(2.9B)(2.2B)(2.3B)(2.4B)
Intangible Assets18.6B82.9B76.0B67.4B55.6B32.2B
Property Plant Equipment3.0B5.2B5.1B4.9B5.7B3.4B
Long Term Debt63.0B77.6B64.2B59.1B52.2B41.2B
Short Long Term Debt Total66.7B86.1B76.7B63.3B59.4B49.8B
Non Currrent Assets Other1.2B1.2B1.9B3.4B6.6B6.9B
Short Term Debt3.8B8.5B12.5B4.1B7.2B5.2B
Net Tangible Assets(42.4B)(102.9B)(96.2B)(82.3B)(74.1B)(77.8B)
Retained Earnings4.7B1.1B3.1B4.8B(1B)(950M)
Retained Earnings Total Equity4.7B1.1B3.1B4.8B5.5B3.4B
Long Term Debt Total63.0B77.6B64.2B59.1B68.0B50.1B
Capital Surpluse15.2B17.4B18.3B19.2B22.1B15.8B
Deferred Long Term Liab1.1B3.6B3.0B2.2B2.5B2.8B

AbbVie Investors Sentiment

The influence of AbbVie's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in AbbVie. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to AbbVie's public news can be used to forecast risks associated with an investment in AbbVie. The trend in average sentiment can be used to explain how an investor holding AbbVie can time the market purely based on public headlines and social activities around AbbVie Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AbbVie's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AbbVie's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average AbbVie's news discussions. The higher the estimated score, the more favorable is the investor's outlook on AbbVie.

AbbVie Implied Volatility

    
  23.37  
AbbVie's implied volatility exposes the market's sentiment of AbbVie Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if AbbVie's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that AbbVie stock will not fluctuate a lot when AbbVie's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AbbVie in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AbbVie's short interest history, or implied volatility extrapolated from AbbVie options trading.

Pair Trading with AbbVie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbbVie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will appreciate offsetting losses from the drop in the long position's value.

Moving together with AbbVie Stock

  0.89EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against AbbVie Stock

  0.9MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.9VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.82KA Kineta Inc Report 29th of March 2024 PairCorr
  0.81CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr
  0.8DBVT DBV Technologies Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to AbbVie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbbVie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbbVie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbbVie Inc to buy it.
The correlation of AbbVie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbbVie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbbVie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbbVie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for AbbVie Stock analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is AbbVie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.67)
Dividend Share
5.99
Earnings Share
2.72
Revenue Per Share
30.723
Quarterly Revenue Growth
(0.05)
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.